Semaglutide: How the GLP-1 Molecule That Revolutionized Weight Loss Works

D
DOZA Team

Weight Management and Healthy Lifestyle Experts

⏱️ 11 min read
Share:
Semaglutide GLP-1 hormone for weight loss — woman with Ozempic pen on sunny city balcony
Семаглутід змінив підхід до схуднення. Одна ін'єкція на тиждень — контроль апетиту без голоду.

One Molecule — Three Brands. How to Understand Semaglutide

  • Buy Ozempic in Ukraine — original Ozempic (semaglutide) FlexTouch from Novo Nordisk, doses 0.25 / 0.5 / 1.0 mg. Cold chain 2–8°C, verified serial number, Bolt/Glovo delivery within 2 hours in Kyiv or Nova Poshta 1–2 days throughout Ukraine. Ozempic price 2026 — from 8,500 ₴ per pen, free DOZA specialist consultation before ordering.

When you hear about weight loss injections, Ozempic and Wegovy are often mentioned. In reality, these are the same drug — semaglutide. It's just sold under different names for different purposes. One for diabetes, another for obesity. A third as tablets instead of injections.

Semaglutide became the substance that proved: weight loss is not a matter of willpower. It's a matter of hormones. Over nine years from diabetes approval to obesity approval, this molecule has been studied more thoroughly than anything else on the market.

Since February 2021, when the first STEP study results were published in the New England Journal of Medicine, the weight loss medication landscape changed forever.

What is Semaglutide? Simple Explanation of Something Complex

Semaglutide is a synthetic GLP-1 hormone analogue developed by Novo Nordisk. It's 94% identical to human GLP-1 and acts as a powerful appetite and body weight regulator [2].

The molecule has two key differences from the natural hormone: two substituted amino acids and a fatty acid (C20) that allows the molecule to last much longer in the body. So instead of daily injections, you take one per week.

ℹ️Simply About Complex

Уявіть, що природний GLP-1 — це радіостанція, сигнал якої діє кілька хвилин. Семаглутід — це той же сигнал, але посилений й защитаний спеціальним екраном, який розтягує дію аж на тиждень. Одна ін'єкція — і весь тиждень ваш апетит залишається під контролем.

Novo Nordisk began semaglutide development in 2008. First approval for type 2 diabetes was in 2017. In 2021, the FDA approved it for obesity — that's when the highest 2.4 mg weekly dose appeared for people without diabetes [2].

This was a breakthrough moment. For the first time in history, a large-scale study showed you could reduce weight by 15% through medication, not just starvation.

Семаглутід молекула структура лабораторна модель з етикеткою
Молекула семаглутіду — синтетичний аналог природного GLP-1 гормону

Ozempic, Wegovy, Rybelsus — One Semaglutide, Different Brands

The biggest confusion arises here. All three medications contain the same active ingredient — semaglutide. But they're registered for different purposes and in different doses.

Семаглутід: три бренди, одна молекула

КритерійOzempic (Оземпік)Wegovy (Вегові)Rybelsus (Рибелсус)
**Активна речовина**СемаглутідСемаглутідСемаглутід
**Максимальна доза**2 мг/тиж.2.4 мг/тиж.14 мг/день
**Форма**Ін'єкціяІн'єкціяТаблетки
**Показання**Діабет 2 типуОжирінняДіабет 2 типу
**Частота**1 раз/тиждень1 раз/тиждень1 раз/день
**Країна надання**FDA (2017)FDA (2021)FDA (2019)

Ozempic is the first version for diabetes patients. Maximum dose 2 mg weekly. Diabetics need less because the main goal is lowering blood sugar, not maximum weight loss.

Wegovy is the same semaglutide but in a higher 2.4 mg weekly dose. Specifically approved for people with obesity without diabetes. This is the dose used in the STEP study [2].

Rybelsus are semaglutide tablets, from 3 mg to 14 mg daily. Taken orally once daily. Only approved for diabetes, not obesity.

Why such dose differences? Because injections have better bioavailability (go directly into bloodstream) than tablets (absorbed through stomach). Plus, when treating obesity, you can tolerate more side effects than with diabetes, where safety is more important.

Озем пік Вегові Рибелсус препарати для схуднення порівняння упаковок
Три форми семаглутіду: Ozempic для діабету, Wegovy для схуднення, Rybelsus таблетки

How Semaglutide Helps Weight Loss: Mechanism of Action

Semaglutide works through GLP-1 receptors — special proteins on cells in your hypothalamus (the brain's central appetite regulator). When the molecule activates these receptors, three mechanisms work simultaneously.

Mechanism 1: Appetite Reduction in the Brain

GLP-1 receptors in the hypothalamus control the hunger center. When semaglutide activates these receptors, the brain receives a signal: "Relax, you're not hungry." This signal is more powerful than willpower alone. It's a hormonal command. Result: you eat less without dieting.

Mechanism 2: Delayed Gastric Emptying

Semaglutide slows how quickly food moves from stomach to small intestine. Instead of eating, feeling full after 20 minutes and forgetting about it, you feel satisfied and stay satisfied for 4-5 hours. Food simply stays in the stomach longer.

Mechanism 3: Changed Food "Reward"

When you eat favorite foods, you usually get pleasure from them. This feeling is dopamine — a chemical reward in the brain. Semaglutide modulates dopamine pathways. Result: pizza or chips become less appealing. You can walk past them without emotional distress.

🔬Honestly About Mechanism

Рівень насичення на семаглутіді часто описують так: "Я просто забула про їжу. Запитали мене о 15:00 чи я голодна, а я зрозуміла що вже не їла ціле ранкове". Це не гіпноз. Це гормональна реальність. GLP-1 змінює не розум, а біохімію.

All this happens with one medication, once weekly. That's why semaglutide is so effective — it doesn't fight your nature, it changes it chemically.

STEP-1: The Most Important Weight Loss Study in a Decade

In 2021, the medical world held its breath. STEP-1 study results were published in the New England Journal of Medicine — the most prestigious journal for scientists [2].

What did they show?

14.9%
weight loss over 68 weeks on semaglutide 2.4 mg
Джерело [2]
Жінка результат програми схуднення на семаглутіді STEP-1 дослідження
STEP-1 дослідження показало середню втрату 15.3 кг за 68 тижнів

SELECT: First Proof That Semaglutide Protects the Heart

SELECT is the name of the study that changed our understanding of what GLP-1 medications can do.

17,604 patients, 41 countries, 40 months of observation. This is one of the largest cardiovascular studies in recent years.

Key feature: unlike previous studies, SELECT didn't include people with diabetes. Participants had obesity and existing cardiovascular problems (previous heart attack, stroke, or peripheral artery disease), but without diabetes.

What were the results?

20%
reduction in cardiovascular events (heart attack, stroke, death)
Джерело [1,3]

At first glance, tirzepatide wins: -22.5% vs -14.9%. That's 50% more effective.

But here's the important difference. Tirzepatide is a dual agonist: activates BOTH receptors — GLP-1 and GIP. GIP is another hormone that also affects appetite. The combination of two gives a greater effect.

Semaglutide only activates GLP-1.

Where semaglutide wins:

  1. More safety evidence: SELECT provided cardioprotection. Tirzepatide doesn't have such large studies.
  2. Tablet form: Rybelsus allows avoiding injections. Tirzepatide only has pens.
  3. More experience: Semaglutide has been on the obesity market since 2021, tirzepatide since 2022-23. More long-term data.

For a complete comparison, we recommend reading the detailed article about Mounjaro vs Ozempic.

Кардіолог серцево-судинна безпека семаглутіду SELECT дослідження
SELECT дослідження довело зниження серцево-судинних подій на 20%

Semaglutide Side Effects: What Really Happens

Semaglutide is well tolerated by many people, but side effects do occur.

Most common:

  • Nausea: 15-20% of people, usually in the first 2-4 weeks
  • Diarrhea: about 10%
  • Constipation: about 5%

Most of these effects resolve themselves within 4-8 weeks as the body adjusts to the medication.

Less common:

  • Severe nausea requiring discontinuation (less than 5%)
  • Pancreatitis (very rare, 0.1-0.3%)
  • Vision changes
💡About OzempicFace

Часто говорять про "OzempicFace" — западання щік та дивне вираження обличчя. Але це не специфічно для семаглутіду. Це наслідок БУДЬ-ЯКОГО швидкого схуднення, коли люди втрачають вагу за короткий час без физичної активності. Шкіра не встигає адаптуватися. Розв'язання: уповільнювати схуднення (поступова титрація), вправи з вагами та дермотерапія.

Important: all side effects are monitored by specialists. Dose can be changed, medication can be discontinued. You're not alone in this process.

Мунджаро Оземпік порівняння консультація спеціаліста DOZA
Спеціаліст допоможе обрати оптимальний препарат саме для вас

Where to Buy Semaglutide in Ukraine and How Much It Costs

Semaglutide (under the Ozempic brand) is available in Ukraine through DOZA. This is the original product from Novo Nordisk, manufactured in the UK.

The medication comes as FlexTouch pens with 4 pre-filled doses. Cold chain is maintained from collection start to delivery at your home.

To get started, you can try a test dose from ₴1,500 — this allows checking medication tolerance before buying a full package.

All DOZA clients receive:

  • Specialist consultation before starting
  • Titration plan (gradual dose increase)
  • Support throughout the entire program
  • Cold chain home delivery

Learn more about the Ozempic program or go to the catalog.

For those who, after this GLP-1 analysis, are considering a stronger alternative — tirzepatide (GLP-1 + GIP), buy Mounjaro in Ukraine directly through DOZA: UK-original KwikPen Eli Lilly with all 6 doses (2.5–15 mg), thermobox 2–8 °C, verified serial number. Thermal delivery 1–2 days throughout Ukraine. Before switching from semaglutide to tirzepatide — free DOZA specialist consultation.

FAQ: Frequently Asked Questions About Semaglutide

Conclusion: Why Semaglutide Changed Weight Loss

Semaglutide showed that weight loss is not a matter of willpower. It's hormonal reality. When the right molecule activates the right receptors, the body listens.

DOZA STEP studies proved this scientifically. SELECT study showed that benefits go beyond just numbers on the scale — it's heart protection.

There are two important points:

  1. Semaglutide works best in combination with diet and exercise. The medication removes the psychological burden (appetite), but discipline is still needed.
  2. This is not an "obesity cure" in the classic sense. It's more like a personal trainer for your appetite. When you stop the medication, appetite returns. But with acquired habits, weight usually doesn't return completely.

If you are considering semaglutide, book a consultation with DOZA. A specialist will assess whether the medication is suitable for you, select the dose, and accompany you throughout the program.

The first step is understanding. The second is action.

Дізнайтесь чи підходить вам семаглутід. Записатися можна за 5 хвилин.

Безкоштовна консультація спеціаліста DOZA

📚 Sources & references

  1. 1
    International Clinical Trial Finds that Semaglutide Reduced Cardiovascular Events by 20% in Adults with Overweight or Obesity Who Don't Have Diabetes

    SELECT trial результати: 20% зниження серцево-судинних подій (MACE), 9.4% втрата ваги, 17,604 учасників, Novo Nordisk, NEJM 2023

  2. 2
    STEP-1 Trial: Semaglutide Treatment Effect in People with Obesity

    Результати STEP-1: -14.9% втрати ваги за 68 тижнів на семаглутіді 2.4 мг, 1,961 учасників, -15.3 кг абсолютна втрата, 86.4% досягли 5% втрати, NEJM 2021

  3. 3
    The SELECT Trial: Semaglutide Cut Heart Risk 20%

    Детальний аналіз SELECT: hazard ratio 0.80, 6.5% vs 8.0% CV подій, 39.8 місяців спостереження, SUSTAIN-6 порівняння, heart failure benefits

  4. 4
    Real-World Weight Loss and Telehealth Platform Utilization Patterns of Long-Term GLP-1 Receptor Agonist Treatment

    Real-world дані про STEP-1 результати, 14.9% втрати ваги, порівняння з тирзепатідом (SURMOUNT-1 -22.5%), тирзепатід emerging as dual GIP+GLP-1 агоніст

  5. 5
    SELECT Trial Analysis Shows Semaglutide's Heart Benefits Extend Beyond Weight Loss

    SELECT результати показали CV користь незалежно від ваги, early weight loss не предиктор CV outcomes, greater waist circumference reductions

❓ FAQ

Anastasia Shapoval — metabolic programs and weight control specialist DOZA

It's a synthetic hormone that mimics natural GLP-1. It reduces appetite, slows food emptying from the stomach, and changes how your brain perceives food pleasure. Result: you eat less without feeling hungry.

Anastasia Shapoval

Metabolic Programs and Weight Control Specialist

Enjoyed this article? Share it with friends!

Share:
D

Article author

DOZA Team

Weight Management and Healthy Lifestyle Experts

The DOZA team of specialists with years of experience in personalized weight loss programs with Mounjaro. Every article is reviewed by experts and based on current scientific research.

Ліцензія МОЗ УкраїниЕндокринологіяГастроентерологіяGLP-1/GIP терапія

About DOZA

DOZA is Ukraine's leading online medical weight-loss support service based on tirzepatide (Mounjaro) and GLP-1. Operating since 2023, 2,147+ clients, 24/7 specialist support, cold chain delivery across Ukraine.

Information verified

Anastasia Shapoval

Metabolic Programs and Weight Control Specialist

Olena Kovalchuk

Medical Reviewer, Endocrinologist

Updated

⚕️Important information

The materials in this article are for informational purposes only. Please consult a specialist before starting any weight management program. For a free consultation message us on Telegram.

Ozempic in Ukraine

Original semaglutide by Novo Nordisk — with delivery and 24/7 specialist support

Choose →

Ready to start?

Message us — a specialist will select a program for you in 5 minutes. Free of charge.

💬 Message on Telegram

Free consultation • We respond 24/7